Tanya Simuni, MD, was awarded a grant from the National Institutes of Health to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson’s disease.
Menu
Browsing: Neurology and Neuroscience
M. Marsel Mesulam, MD, director of the Cognitive Neurology and Alzheimer’s Disease Center, will travel to Philadelphia at the end of April to be honored at the annual American Academy of Neurology meeting.
Developed by Gregory Dumanian, MD, and Todd A Kuiken, MD, PhD, targeted muscle reinnervation enables an amputee to control motorized prosthetic devices and regain sensory feedback. New research also shows that it reduces neuroma pain from cut nerve endings.
The Disterhoft lab has illustrated how neuronal activity varies in the pre-frontal cortex as the brain shifts from attention to recollection of long-term memory.
According to a new study, memory rewrites the past with current information, updating your recollections with new experiences.
Dimitri Krainc and Andrew Parsa had only heard of each other before they came to Northwestern Medicine. Now they share a vision as new leaders for the academic and clinical missions in neurology and neurosurgery.
With its recent renewal, Feinberg’s Udall Center of Excellence for Parkinson’s Disease Research is one of 10 such centers funded by the National Institute of Neurological Disorders and Stroke.
Published in the Journal of Neuroscience, a discovery by Marco Martina, MD, PhD, associate professor in Physiology, sheds new light on the selective vulnerability of cell types in preclinical models of ataxia.
P. Hande Ozdinler, PhD, has been awarded three grants totaling more than $2.5 million. The funds will be used to increase her research efforts into the mechanisms behind amyotrophic lateral sclerosis.
While it’s long been known that oxytocin promotes feelings of love, social bonding, and wellbeing, only recently have scientists discovered it’s link to anxiety-producing bad memories.